下载

Centre National de Référence pour les Infections Virales Emergentes (National Reference Center for Emerging Viral Infections)

[按照表格A第2部分(iii)]

2. 负责的公营或私营组织或公司
Virological Laboratory, University Hospitals of Geneva
3. 地点和通信地址
Centre National de Référence pour les Infections Virales Emergentes, Laboratoire de Virologie, Hôpitaux Universitaires de Genève, Rue Gabrielle Perret-Gentil 4, CH-1205 Genève, Switzerland
4. 所报活动的资金来源,包括说明国防部是否为活动提供全部资金或部分资金

Swiss Confederation (Federal Department of Home Affairs)

5. 研究中心和/或实验室内的最高封闭性单元5 数目,说明各单元的大小(平方米)
BL 4 , 36.00 平方米
Of note, the BSL4 unit is operational and holds a license for diagnostic purposes only, as follows: “Detection of viruses in clinical samples by molecular and/or serological methods”.
BL 3 , 39.00 平方米
BL 2 , 29.00 平方米
6. 活动的范围和概况,包括酌情填明有关微生物和/或毒素的类型

The National Reference Center for Emerging Viral Diseases (CRIVE/NAVI) is a national reference laboratory by order of the Federal Office of Public Health. Its task is the detection of emerging and re-emerging viruses of all biosafety levels, especially hemorrhagic fever viruses and smallpox virus. The BSL4 unit is approved for diagnostic purposes only, which does not allow any culturing or enrichment of such viruses. The National Reference Center for Emerging Viral Diseases is part of the Laboratory of Virology at the University Hospitals of Geneva. Since the 1st January 2018, the CRIVE acts also as WHO National Center for Measles and Rubella.

The Laboratory of Virology (LV) performs the analysis of many viruses impacting the human health as done in most of the hospitals (HIV, Hepatitis, CMV, EBV, respiratory and enteric viruses, etc.). LV does most of the viral analysis needed by a university hospital. LV also hosts the Swiss National Center for Influenza.

For further information please visit (website in French):
https://www.hug-ge.ch/laboratoire-virologie

(4) 对于参加国家生物战防御研究与发展方案的、有最高封闭性单元的设施,请填明设施名称并注明“根据表格A第2 (三)部分宣布”。

(5) 根据1983年世界卫生组织《实验室生物安全手册》或同等标准。